Literature DB >> 1826839

Kinetic modelling of chloroquine uptake by malaria-infected erythrocytes. Assessment of the factors that may determine drug resistance.

H Ginsburg1, W D Stein.   

Abstract

The antimalarial chloroquine, by virtue of its weak base properties, concentrates in the acidic compartment(s) of the intraerythrocytic parasite. Drug accumulation is essential for it to exert its pharmacological activity. Drug resistance has been thought to result from insufficient acidification of drug-accumulating organelle(s), (due to weakened proton pump activity and/or proton leak) or to result from the action of the recently suggested active efflux drug pump. In this work we have devised a kinetic model which takes into account the various processes that have been postulated to account for acidification and drug fluxes. Using this model to analyse the time-course of chloroquine uptake and the steady-state levels of drug accumulation, in strains of Plasmodium falciparum which display variable drug resistance, we demonstrate that drug resistance is compatible with the existence of a weakened proton pump in the resistant parasite strains. Consistent with recent molecular studies that show no correlation between the presence of the multidrug efflux pump gene and the phenotypic expression of chloroquine resistance, our analysis fails to detect any such pump activity. We also show that analysis of drug efflux kinetics cannot distinguish between the possible modes of drug resistance.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1826839     DOI: 10.1016/0006-2952(91)90562-j

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  9 in total

1.  Distribution of mefloquine in the blood of Thai patients with acute uncomplicated falciparum malaria following administration of therapeutic doses of artesunate.

Authors:  Kesara Na-Bangchang; Ronnatrai Ruengweerayut; Walther H Wernsdorfer
Journal:  Eur J Clin Pharmacol       Date:  2011-05-10       Impact factor: 2.953

2.  A critical role for PfCRT K76T in Plasmodium falciparum verapamil-reversible chloroquine resistance.

Authors:  Viswanathan Lakshmanan; Patrick G Bray; Dominik Verdier-Pinard; David J Johnson; Paul Horrocks; Rebecca A Muhle; George E Alakpa; Ruth H Hughes; Steve A Ward; Donald J Krogstad; Amar Bir Singh Sidhu; David A Fidock
Journal:  EMBO J       Date:  2005-06-09       Impact factor: 11.598

Review 3.  [Malaria--biological aspects of an infectious disease of importance to humans].

Authors:  J P Hildebrandt
Journal:  Naturwissenschaften       Date:  1996-08

4.  Expression of the plasmodial pfmdr1 gene in mammalian cells is associated with increased susceptibility to chloroquine.

Authors:  H H van Es; S Karcz; F Chu; A F Cowman; S Vidal; P Gros; E Schurr
Journal:  Mol Cell Biol       Date:  1994-04       Impact factor: 4.272

Review 5.  Multidrug resistance and P-glycoproteins in parasitic protozoa.

Authors:  B Ullman
Journal:  J Bioenerg Biomembr       Date:  1995-02       Impact factor: 2.945

6.  Differential stimulation of the Na+/H+ exchanger determines chloroquine uptake in Plasmodium falciparum.

Authors:  S Wünsch; C P Sanchez; M Gekle; L Grosse-Wortmann; J Wiesner; M Lanzer
Journal:  J Cell Biol       Date:  1998-01-26       Impact factor: 10.539

7.  Cellular uptake of chloroquine is dependent on binding to ferriprotoporphyrin IX and is independent of NHE activity in Plasmodium falciparum.

Authors:  P G Bray; O Janneh; K J Raynes; M Mungthin; H Ginsburg; S A Ward
Journal:  J Cell Biol       Date:  1999-04-19       Impact factor: 10.539

8.  Selection for high-level chloroquine resistance results in deamplification of the pfmdr1 gene and increased sensitivity to mefloquine in Plasmodium falciparum.

Authors:  D A Barnes; S J Foote; D Galatis; D J Kemp; A F Cowman
Journal:  EMBO J       Date:  1992-08       Impact factor: 11.598

9.  Gender-specific distribution of mefloquine in the blood following the administration of therapeutic doses.

Authors:  Walther H Wernsdorfer; Harald Noedl; Pamela Rendi-Wagner; Herwig Kollaritsch; Gerhard Wiedermann; Andrea Mikolasek; Juntra Karbwang; Kesara Na-Bangchang
Journal:  Malar J       Date:  2013-12-09       Impact factor: 2.979

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.